EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Adverse Reactions The Fenoterol Story 1st Edition Neil Pearce

Name: Adverse Reactions The Fenoterol Story 1st Edition Neil Pearce
SKU: BELL-5853108
Price: 31.00 USD
Availability: InStock
Rating: 4.1 (60 reviews)

SKU: BELL-5853108

$ 31.00 ~~$ 45.00~~ (-31%)

4.1

60 reviews

Adverse Reactions The Fenoterol Story 1st Edition Neil Pearce instant download after payment.

Publisher: Auckland University Press

File Extension: PDF

File size: 1.53 MB

Pages: 200

Author: Neil Pearce

ISBN: 9781869403744, 1869403746

Language: English

Year: 2007

Edition: 1

Product desciption

Adverse Reactions The Fenoterol Story 1st Edition Neil Pearce by Neil Pearce 9781869403744, 1869403746 instant download after payment.

Recounting the fenoterol epidemic—a major medical controversy that took place more than 15 years ago—this narrative explores the involvement of the asthma drug that caused numerous asthma deaths. Although the epidemic occurred in New Zealand, its shocking discoveries and subsequent consequences attracted worldwide attention in medical journals and conferences. Neil Pearce, the researcher who discovered that fenoteral was the cause of the epidemic, tells this personal story while raising concerns about drug safety internationally and analyzing the battle between money and science in medical research.